Literature DB >> 28279666

Pediatric Heart Failure: A Practical Guide to Diagnosis and Management.

Daniele Masarone1, Fabio Valente2, Marta Rubino2, Rossella Vastarella2, Rita Gravino2, Alessandra Rea2, Maria Giovanna Russo2, Giuseppe Pacileo2, Giuseppe Limongelli2.   

Abstract

Pediatric heart failure represents an important cause of morbidity and mortality in childhood. Currently, there are well-established guidelines for the management of heart failure in the adult population, but an equivalent consensus in children is lacking. In the clinical setting, ensuring an accurate diagnosis and defining etiology is essential to optimal treatment. Diuretics and angiotensin-converting enzyme inhibition are the first-line therapies, whereas beta-blockers and devices for electric therapy are less used in children than in adults. In the end-stage disease, heart transplantation is the best choice of treatment, while a left ventricular assist device can be used as a bridge to transplantation (due to the difficulties in finding organ donors), recovery (in the case of myocarditis), or destination therapy (for patients with systemic disease).
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  cardiomyopathies; congenital heart diseases; pediatric cardiac transplantation; pediatric heart failure

Mesh:

Substances:

Year:  2017        PMID: 28279666     DOI: 10.1016/j.pedneo.2017.01.001

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  13 in total

1.  Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects.

Authors:  Ashit Trivedi; Mia Mackowski; Pegah Jafarinasabian; Hanze Zhang; Stephen Flach; Bianca Terminello; Ajay Bhatia; Sandeep Dutta; Edward Lee
Journal:  Clin Drug Investig       Date:  2021-06-10       Impact factor: 2.859

Review 2.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

3.  Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.

Authors:  Anna Bauer; Markus Khalil; Monika Lüdemann; Jürgen Bauer; Anoosh Esmaeili; Roberta De-Rosa; Norbert F Voelkel; Hakan Akintuerk; Dietmar Schranz
Journal:  Clin Res Cardiol       Date:  2018-04-16       Impact factor: 5.460

4.  Safety and efficacy of the endothelin receptor antagonist macitentan in pediatric pulmonary hypertension.

Authors:  Sabrina Schweintzger; Martin Koestenberger; Axel Schlagenhauf; Gernot Grangl; Ante Burmas; Stefan Kurath-Koller; Mirjam Pocivalnik; Hannes Sallmon; Daniela Baumgartner; Georg Hansmann; Andreas Gamillscheg
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

5.  Preterm birth and prescriptions for cardiovascular, antiseizure, antibiotics and antiasthmatic medication in children up to 10 years of age: a population-based data linkage cohort study across six European regions.

Authors:  Mads Damkjaer; Maria Loane; Stine Kjær Urhøj; Elisa Ballardini; Clara Cavero-Carbonell; Alessio Coi; Laura García-Villodre; Joanne Emma Given; Mika Gissler; Anna Heino; Susan Jordan; Amanda Neville; Anna Pierini; Joachim Tan; Ieuan Scanlon; Ester Garne; Joan K Morris
Journal:  BMJ Open       Date:  2022-10-17       Impact factor: 3.006

6.  Influence of targeted motivational interviewing on self-care level and prognosis during nursing care of chronic heart failure.

Authors:  Jianfei Wu; Yilan Yu; Huan Xu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 7.  A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments?

Authors:  Mindong Ren; Paighton C Miller; Michael Schlame; Colin K L Phoon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-11       Impact factor: 4.733

8.  Evaluation of Clinical Course and Maintenance Drug Treatment of Supraventricular Tachycardia in Children During the First Years of Life. A Cohort Study from Eastern Germany.

Authors:  Claudio Bücking; Anna Michaelis; Franziska Markel; Michael Weidenbach; Ingo Dähnert; Roman Antonin Gebauer; Christian Paech
Journal:  Pediatr Cardiol       Date:  2021-09-15       Impact factor: 1.655

9.  Association of Preoperative Diuretic Use With Early Acute Kidney Injury in Infants With Biventricular Hearts Following Cardiac Surgery.

Authors:  Steven L Rathgeber; Adrija Chakrabarti; Eva Kapravelou; Nicole Hemphill; Christine Voss; Cherry Mammen; Peter Skippen; Kevin C Harris
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

10.  Value of Galectin-3 assay in children with heart failure secondary to congenital heart diseases: a prospective study.

Authors:  Nagwan Saleh; Ahmed Khattab; Mohamed Rizk; Sherif Salem; Hany Abo-Haded
Journal:  BMC Pediatr       Date:  2020-11-28       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.